<DOC>
	<DOCNO>NCT00819897</DOCNO>
	<brief_summary>The aim study evaluate role cognitive disorder quality life patient CIS , consider high risk develop MS , treat interferon Beta . This prospective observational study include 120 patient , treat evaluate annually neurological extensive examination , ophthalmologic screening ( OCT , OF , VEP , VF ) , auto questionnaire fatigue ( musicol , ELIF ) , quality life ( SEP-59 ) , conventional MRI .</brief_summary>
	<brief_title>Longitudinal Study Clinically Isolated Syndrome ( CIS ) Patients Treated With Interferon Beta</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<criteria>Patients older 18 year , Patients CIS temporo spatial dissemination less one year Patient without prior immunomodulatory treatment Patient inform CIS diagnosis MS accord McDonald criterion , Patients EDSS inferior egal 5,5 Patients usually frenchreader MMS &gt; 24 Patients inform study protocol Patients agree sign inform consent Patients affiliation number social French département . Secondary progressive MS Patient acute relapse Patient already treat IFN corticosteroid less 15 day Patient severe dépressive disorder Patient already include clinical study Patient &lt; 18 year Patient know contra indication beta interféron Every reason provoke interruption study , regard patient empechment Contre indication MRI test require study pregnancy lactation patient Under juridic protection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>MS</keyword>
	<keyword>CIS</keyword>
	<keyword>IFN</keyword>
	<keyword>MRI</keyword>
	<keyword>OCT</keyword>
	<keyword>QOL</keyword>
</DOC>